Literature DB >> 28870545

Arterial stiffness and cognitive impairment.

Xiaoxuan Li1, Peiyuan Lyu2, Yanyan Ren1, Jin An3, Yanhong Dong4.   

Abstract

BACKGROUND: Arterial stiffness is one of the earliest indicators of changes in vascular wall structure and function and may be assessed using various indicators, such as pulse-wave velocity (PWV), the cardio-ankle vascular index (CAVI), the ankle-brachial index (ABI), pulse pressure (PP), the augmentation index (AI), flow-mediated dilation (FMD), carotid intima media thickness (IMT) and arterial stiffness index-β. Arterial stiffness is generally considered an independent predictor of cardiovascular and cerebrovascular diseases. To date, a significant number of studies have focused on the relationship between arterial stiffness and cognitive impairment. OBJECTIVES AND METHODS: To investigate the relationships between specific arterial stiffness parameters and cognitive impairment, elucidate the pathophysiological mechanisms underlying the relationship between arterial stiffness and cognitive impairment and determine how to interfere with arterial stiffness to prevent cognitive impairment, we searched PUBMED for studies regarding the relationship between arterial stiffness and cognitive impairment that were published from 2000 to 2017. We used the following key words in our search: "arterial stiffness and cognitive impairment" and "arterial stiffness and cognitive impairment mechanism". Studies involving human subjects older than 30years were included in the review, while irrelevant studies (i.e., studies involving subjects with comorbid kidney disease, diabetes and cardiac disease) were excluded from the review.
RESULTS: We determined that arterial stiffness severity was positively correlated with cognitive impairment. Of the markers used to assess arterial stiffness, a higher PWV, CAVI, AI, IMT and index-β and a lower ABI and FMD were related to cognitive impairment. However, the relationship between PP and cognitive impairment remained controversial. The potential mechanisms linking arterial stiffness and cognitive impairment may be associated with arterial pulsatility, as greater arterial pulsatility damages the cerebral microcirculation, which causes various phenomena associated with cerebral small vessel diseases (CSVDs), such as white matter hyperintensities (WMHs), cerebral microbleeds (CMBs), and lacunar infarctions (LIs). The mechanisms underlying the relationship between arterial stiffness and cognitive impairment may also be associated with reductions in white matter and gray matter integrity, medial temporal lobe atrophy and Aβ protein deposition. Engaging in more frequent physical exercise; increasing flavonoid and long-chain n-3 polyunsaturated fatty acid consumption; increasing tea, nitrite, dietary calcium and vitamin D intake; losing weight and taking medications intended to improve insulin sensitivity; quitting smoking; and using antihypertensive drugs and statins are early interventions and lifestyle changes that may be effective in preventing arterial stiffness and thus preventing cognitive impairment.
CONCLUSION: Arterial stiffness is a sensitive predictor of cognitive impairment, and arterial stiffness severity has the potential to serve as an indicator used to facilitate treatments designed to prevent or delay the onset and progression of dementia in elderly individuals. Early treatment of arterial stiffness is beneficial and recommended.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ankle-brachial index; Arterial stiffness; Cognitive impairment; Pulse-wave velocity

Mesh:

Year:  2017        PMID: 28870545     DOI: 10.1016/j.jns.2017.06.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  24 in total

Review 1.  Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.

Authors:  Heeyoung Lee; EunYoung Kim
Journal:  Arch Pharm Res       Date:  2020-09-09       Impact factor: 4.946

Review 2.  Blood Pressure Control and Protection of the Aging Brain.

Authors:  Nasratullah Wahidi; Alan J Lerner
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

3.  Memory impairment in spontaneously hypertensive rats is associated with hippocampal hypoperfusion and hippocampal vascular dysfunction.

Authors:  Abbie C Johnson; Justin E Miller; Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2019-05-14       Impact factor: 6.200

4.  Arterial damage and cognitive impairment in patients with chronic kidney disease.

Authors:  Despina Karasavvidou; Rigas Kalaitzidis; Moses Elisaf
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-07       Impact factor: 3.738

5.  Arterial damage and cognitive impairment in patients with chronic kidney disease.

Authors:  Tomoyuki Kawada
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-07       Impact factor: 3.738

6.  Breast Arterial Calcification Is Not Associated with Mild Cognitive Impairment or Incident All-Cause Dementia Among Postmenopausal Women: The MINERVA Study.

Authors:  Carlos Iribarren; Malini Chandra; Sabee Molloi; Gabriela Sanchez; Fatemeh Azamian-Bidgoli; Hyo-Min Cho; Huanjun Ding; Kristine Yaffe
Journal:  J Womens Health (Larchmt)       Date:  2020-12-07       Impact factor: 3.017

7.  Cognitive and vascular function in older adults with and without CKD.

Authors:  Mary Hannan; Eileen G Collins; Shane A Phillips; Lauretta Quinn; Alana Steffen; Ulf G Bronas
Journal:  Aging Clin Exp Res       Date:  2020-09-09       Impact factor: 4.481

8.  Vitamin D deficiency causes inward hypertrophic remodeling and alters vascular reactivity of rat cerebral arterioles.

Authors:  Éva Pál; Leila Hadjadj; Zoltán Fontányi; Anna Monori-Kiss; Zsuzsanna Mezei; Norbert Lippai; Attila Magyar; Andrea Heinzlmann; Gellért Karvaly; Emil Monos; György Nádasy; Zoltán Benyó; Szabolcs Várbíró
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

9.  An association analysis between hypertension, dementia, and depression and the phases of pre-sarcopenia to sarcopenia: A cross-sectional analysis.

Authors:  Takeshi Endo; Kenju Akai; Tsunetaka Kijima; Shigetaka Kitahara; Takafumi Abe; Miwako Takeda; Toru Nabika; Shozo Yano; Minoru Isomura
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

10.  Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism.

Authors:  Yufeng Lin; Kaiyuan Wang; Chunchao Ma; Xuesong Wang; Zhongying Gong; Rui Zhang; Dawei Zang; Yan Cheng
Journal:  Front Aging Neurosci       Date:  2018-07-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.